| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_602e183e329d908e2c09f9b9141a6962 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-422 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 |
| filingDate |
2013-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe7ca4f0938645738b4a013f35477846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca13c71209278550c7a814bd662dffdc |
| publicationDate |
2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2622386-C2 |
| titleOfInvention |
Derivatives of sitaxenthan |
| abstract |
FIELD: pharmacology. n SUBSTANCE: invention relates to N-(4-chloro-3-methyl-1.2-oxazol-5-yl)-2-[2-(6-methyl-1.3-dihydro-2-benzofuran-5-yl)acetyl]thiophene-3-sulfonamide or a pharmacologically acceptable salt thereof. The compound of the invention is intended as an endothelin receptor antagonist or therapeutic or prophylactic agent for the treatment of pulmonary arterial hypertension. n EFFECT: compound that maintains the main therapeutic effect of sitaxentan and has an improved CYP inhibitory effect. n 3 cl, 4 tbl, 3 dwg, 3 ex |
| priorityDate |
2012-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |